• Contact us
  • Access
    • Japanese
    • English
    • 한국어
    • 簡体中文
    • 繁體中文
This page does not support translation languages. ×
Tomohito Kakegawa Tomohito Kakegawa

Tomohito Kakegawa

KAKEGAWA Tomohito

Department of Pharmaceutical Sciences

area of expertise: To elucidate the targets of physiologically active substances and their mechanisms of action in order to ensure the safety of pharmaceuticals

Main subjects

・Advanced Pharmaceutical Sciences ・Advanced Seminar on Pharmacoepidemiology ・Advanced Seminar on Regional Medicine ・Special Seminar on Graduate School ・Special Lecture on Graduate School ・Advanced Seminar on Medical Pharmacy

Research Themes and Keywords

Gene expression regulation mechanism

Final academic background/degree

Chiba /Doctor of Pharmacy

licence · Qualification

pharmacist

Affiliated academic society

Pharmaceutical Society of Japan, Japanese Biochemical Society, Japanese Society of Wound Healing, Japanese Association of Hospital Pharmacists, Chiba Pharmacists Association, Japanese Cosmetic Science Society, etc.

Major achievements

1. Hidehisa Sasaki, Akiko Suzuki, Junko Miyazawa, Eiko Ii, Kenji Mori, Yujin Kakegawa, Kenji Sugibayashi: A study of vaccination motivations and adverse reactions in the workplace vaccination program for COVID-19 Josai International University. Journal of the Japanese Society for Preventive Medicine 16(2):21-26, 2022.
2. Hidehisa Sasaki, Hiroaki Nakasa, Koji Kase, Tamami Ono, Toshihiro Suzuki, Kenichi Kikuchi, Yujin Kakegawa, Kenji Sugibayashi: Efforts by pharmacists in pharmacies, hospitals, and university faculty regarding COVID-19 vaccination services in Togane City, Sanmu City, and Oamishirasato City, Chiba Prefecture. Journal of the Japanese Society for Preventive Medicine 16(2):27-33, 2022.
3.T. Kakegawa, LS Yoshida, M. Takada, M. Noguchi, K. Yasukawa, H. Takano-Ohmuro. Comparison of the effects of pachymic acid, moronic acid and hydrocortisone on the polysome loading of RNAs in lipopolysaccharide‑treated THP‑1 macrophages. J. Nat. Med. 73 ,190-201 (2018).

For detailed Research achievements, see Here
or Here

message

New Drugs New Tricks